David Mankoff

614 total citations
14 papers, 439 citations indexed

About

David Mankoff is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Cancer Research. According to data from OpenAlex, David Mankoff has authored 14 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in David Mankoff's work include Medical Imaging Techniques and Applications (8 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and MRI in cancer diagnosis (3 papers). David Mankoff is often cited by papers focused on Medical Imaging Techniques and Applications (8 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and MRI in cancer diagnosis (3 papers). David Mankoff collaborates with scholars based in United States, Ireland and France. David Mankoff's co-authors include Michael Muzi, Lucy Sasongko, Jashvant D. Unadkat, Xin Yang, Elif Hindié, Alexandre Cochet, Jean‐Louis Alberini, David Groheux, Olivier Humbert and Jennifer R. Bellon and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Statistical Association and Cancer Research.

In The Last Decade

David Mankoff

14 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Mankoff United States	5	244	177	142	86	69	14	439
Kazutoshi Yokoyama Japan	11	65 0.3×	193 1.1×	32 0.2×	30 0.3×	12 0.2×	26	390
Alexander Traxl Austria	11	239 1.0×	62 0.4×	119 0.8×	13 0.2×	22 0.3×	17	326
T. Fujiwara Japan	9	68 0.3×	285 1.6×	24 0.2×	80 0.9×	10 0.1×	13	480
Xi-Shan Hao China	10	137 0.6×	21 0.1×	34 0.2×	30 0.3×	21 0.3×	17	377
Anne‐Joy M. de Graan Netherlands	12	282 1.2×	20 0.1×	52 0.4×	28 0.3×	10 0.1×	16	425
Michael Z. Liao United States	12	180 0.7×	66 0.4×	84 0.6×	12 0.1×	3 0.0×	24	384
Amy A. Irving United States	13	84 0.3×	128 0.7×	10 0.1×	62 0.7×	10 0.1×	18	415
Elisabeth del Río Spain	14	221 0.9×	18 0.1×	29 0.2×	81 0.9×	21 0.3×	24	633
Claire Padgett United States	7	65 0.3×	11 0.1×	42 0.3×	24 0.3×	45 0.7×	11	294

Countries citing papers authored by David Mankoff

Since Specialization

Citations

This map shows the geographic impact of David Mankoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mankoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mankoff more than expected).

Fields of papers citing papers by David Mankoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Mankoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mankoff. The network helps show where David Mankoff may publish in the future.

Co-authorship network of co-authors of David Mankoff

This figure shows the co-authorship network connecting the top 25 collaborators of David Mankoff. A scholar is included among the top collaborators of David Mankoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Mankoff. David Mankoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Taïeb, David, Elif Hindié, & David Mankoff. (2021). A Bright Future for Nuclear Endocrinology. Journal of Nuclear Medicine. 62(Supplement 2). 1S–2S. 2 indexed citations

Sellmyer, Mark A., Sarah A. Richman, Catherine Hou, et al.. (2018). In vivo monitoring of CAR T cells using [18F]fluoropropyl-trimethoprim. 59. 122–122. 1 indexed citations

Peterson, Lanell M., Vicky Wu, Isaac Jenkins, et al.. (2018). 18F-Fluoroestradiol (FES) and18F-Fluorodeoxyglucose (FDG) PET imaging in male breast cancer. 59. 54–54. 2 indexed citations

O’Sullivan, Finbarr, Janet OʼSullivan, Jian Huang, et al.. (2017). Assessment of a statistical AIF extraction method for dynamic PET studies with 15O water and 18F fluorodeoxyglucose in locally advanced breast cancer patients. Journal of Medical Imaging. 5(1). 1–1. 4 indexed citations

Peterson, Lanell M., Alena Nováková, Janet OʼSullivan, et al.. (2016). Use of paired FDG and 18F-Fluoride PET to predict response to therapy in patients with bone dominant metastases from breast cancer. 57. 415–415. 1 indexed citations

Groheux, David, Alexandre Cochet, Olivier Humbert, et al.. (2016). ¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer. Journal of Nuclear Medicine. 57(Supplement 1). 17S–26S. 133 indexed citations

Makvandi, Mehran, Brian P. Lieberman, B. C. LeGeyt, et al.. (2015). The development of novel Sigma-2 targeted alpha-emitting radioligand astatine-211-MM3 as a potential radiotherapeutic for breast cancer. 56. 8–8. 2 indexed citations

Fink, James R., Zheng Zhang, Mark Muzi, et al.. (2015). ACRIN 6684: Multicenter phase II assessment of tumor hypoxia in glioblastoma using 18F-Fluoromisonidazole (FMISO) PET and MRI. 56. 325–325. 1 indexed citations

Peterson, Lanell M., Brenda F. Kurland, Jeanne M. Link, et al.. (2010). Factors influencing the uptake of [F-18]fluoroestradiol (FES) in patients with estrogen receptor positive (ER+) breast cancer. Europe PMC (PubMed Central). 51. 178–178. 2 indexed citations

10.

O’Sullivan, Finbarr, Mark Muzi, Alexander M. Spence, et al.. (2009). Nonparametric Residue Analysis of Dynamic PET Data With Application to Cerebral FDG Studies in Normals. Journal of the American Statistical Association. 104(486). 556–571. 22 indexed citations

11.

Kurland, Brenda F., et al.. (2009). DCE-MRI and dynamic FDG PET to monitor breast cancer response to neoadjuvant sunitinib in patients with locally-advanced breast cancer.. Cancer Research. 69(2_Supplement). 6006–6006. 1 indexed citations

12.

Goulart, Bernardo, et al.. (2008). Phase II study of sunitinib in iodine refractory, well-differentiated thyroid cancer (WDTC) and metastatic medullary thyroid carcinoma (MTC). Journal of Clinical Oncology. 26(15_suppl). 6062–6062. 28 indexed citations

13.

Sasongko, Lucy, et al.. (2005). Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography. Clinical Pharmacology & Therapeutics. 77(6). 503–514. 201 indexed citations

14.

Mankoff, David & Jennifer R. Bellon. (2001). Positron-emission tomographic imaging of cancer: Glucose metabolism and beyond*. Seminars in Radiation Oncology. 11(1). 16–27. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact